Vimta Labs (524394) Q4 97/98 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 97/98 earnings summary
28 Oct, 2026Executive summary
FY1997-98 turnover was Rs 250 lakh; reported loss after tax widened to Rs 219.81 lakh from Rs 92.30 lakh, as recession curtailed project and analytical assignments.
The Rostest, Moscow joint venture broadened the service offering to pre-shipment inspection for Indian exports to Russia.
Financial highlights
Income from operations was Rs 233.69 lakh versus Rs 335.67 lakh in FY1996-97; total income, including inventory change and other income, was Rs 250.11 lakh.
Loss before tax and after tax was Rs 219.81 lakh, compared with Rs 92.30 lakh in FY1996-97; no income-tax provision was made.
Finance charges and interest rose to Rs 167.67 lakh from Rs 143.19 lakh; depreciation was Rs 41.71 lakh versus Rs 41.29 lakh.
Outlook and guidance
First-quarter performance was described as encouraging, with enquiries for environmental, bio-availability and pre-shipment inspection work; continued momentum was expected to improve operating results.
The Rostest venture was expected to add annual turnover of Rs 200-300 lakh through pre-shipment inspection services for Indian exports to Russia.
Latest events from Vimta Labs
- Q2 income grew 9.9% as biologics began commercial delivery.524394
Q2 26/27 - Turnover fell and losses emerged, while GLP certification strengthened export prospects.524394
Q4 96/97 - Returned to profit and cleared IDBI term debt through a one-time settlement.524394
Q4 99/00 - Record turnover and higher profit, with equipment upgrades and export growth in focus.524394
Q4 00/01 - Turnover surged 75%, with record exports and expansion plans supporting the outlook.524394
Q4 01/02 - Revenue rose 81%, exports surged, and a fivefold capacity expansion was planned.524394
Q4 03/04 - FY03 growth surged as exports expanded and lab capacity investment accelerated.524394
Q4 02/03 - Net profit rose 66% as exports surged and major lab expansion advanced.524394
Q4 04/05 - Capacity-constrained growth drove expansion, with FY06/07 revenue targeted at Rs.90–100 crore.524394
Q4 05/06